Abstract: Congenital Heart Disease, Pulse Oximetry, Screening
Introduction
Congenital Heart Disease is one of the commonest groups of congenital malformations with an incidence of approximately 8 per 1000 live births, with a higher rate in still births 1 . The risk of death from congenital heart disease has decreased from 30% in the 1970s to less than 5% 1 . It contributes to 3% of all infant mortality and 46% of deaths from congenital malformations with most deaths occurring in the first year of life 2 .
Critical Congenital Heart Defects: CCHD is a group of heart defects that can be life threatening and require medical attention within the first few days or first year of life.
Although individually less common, when taken together, these lesions contribute significantly to death in infancy. If cardiovascular collapse occurs prior to diagnosis, death or poorer outcome following surgery is much more likely. Thus timely recognition of these cardiac defects prior to collapse is vital in order to improve outcome 2 .
Thus the need for an accurate, simple, non-invasive test for CHD in the early neonatal period has led to a number of investigators to examine the use of Pulse Oximetry with encouraging results. Various authors 3, 4 have studied the effectiveness of Pulse Oximetry as a screening tool for CHDs in otherwise asymptomatic newborns and have shown encouraging results with most of the studies showing good sensitivity and specificity of pulse oximetry. Most of the studies observed the newborns within 24 hours or 48 hours of life. But still the ideal age of newborn at which the screening would detect majority of CHDs with less number of false positives due to the physiological changes in the circulation after birth is yet to be decided. Thus in this study the clinical examination and pulse oximetry evaluation of the newborns is conducted on three occasions to have maximum yield of screening and detect the CHDs which may not give any clinical clue at birth.
Materials & Methods
This was a Prospective Clinical Study conducted in the Labour room and Maternity wards of Krishna Institute of Medical Sciences, Karad. All apparently healthy newborns delivered in a period of 1 year (December 2013 to November 2014) were included in the study. Sample size -2761 newborns.
Inclusion Criteria 1) Asymptomatic (for congenital heart disease), term (gestational age ≥ 37 weeks, as per Modified Ballard score) newborns were included in the study. 2) Informed consent given by the parents.
Exclusion Criteria 1) Preterm neonates (gestational age < 37 weeks, as per
Modified Ballard score) were excluded from the study. 2) Neonates with symptoms of presence of congenital heart disease (i.e. presence of tachypnoea, tachycardia, cyanosis, pallor, feeding difficulties, prolonged capillary refilling time) before the first examination and assessment were excluded from the study. 3) Sick neonates and neonates admitted in the NICU (neonatal intensive care unit) were excluded from the study. 4) Neonates already diagnosed as having congenital heart disease in antenatal ultrasound screening were excluded from the study.
A written and informed consent was obtained from the mother for the study and detailed information of the newborn babies was noted. Antenatal, intranatal, perinatal and family history was obtained. Post-Ductal. Pulse oximetry recordings were taken when the oximeter showed a consistent reading for 1 minute.
Neonates with recordings of < 95% on pulse oximeter or > 3% difference between right hand and foot or any positive general or systemic examination finding for CHD in any of the three examinations were further investigated for the presence of congenital heart disease by performing a 2D Echocardiography. Neonates diagnosed to have CHDs were either medically managed at our centre or referred to other centers for surgical management as per the opinion of the pediatric cardiologist.
Results
Total 2761 neonates were screened for Congenital Heart Disease in this study over a period of one year. Out of 2761 neonates: 1492 were male and 1269 were female. The birth weight of < 2.5 kg was noted in 744 babies while 2017 had birth weight of ≥ 2.5 kg. CHD was detected in 23 newborns out of 2761 screened. Thus the occurrence of CHD observed was 8.3/1,000 asymptomatic healthy term newborns. Table 1 and Figure 1 depict the distribution of Congenital heart diseases. Of 2761 neonates; 139 had one of the above significant antenatal history, while in the CHD group; 2 had significant antenatal history such as one had a diabetic mother and the other was a mother with epilepsy on Valproate.
Positive family history for CHD was considered if either of the parents or sibling was suffering from congenital heart disease. 11 had positive family history of heart disease. Only 1 of them was diagnosed to have CHD. Figure 2: Graphical representation of age of diagnosis of congenital heart diseases by physical examination, pulse oximetry and both
Of the 2761 neonates screened, 9 neonates had Cyanotic Congenital Heart Disease and 8 out of them were picked by Pulse Oximetry, while 1 was missed (Table 3) .
27 cases were Positive on Pulse Oximetry screening but did not have Cyanotic CHD, 3 cases were of Persistent Pulmonary Hypertension, 5 cases were of Acyanotic CHD and 19 cases were False Positive cases detected by pulse oximetry screening when it was applied on neonates <24 hours after which the values were normal. 
Discussion
Congenital heart defects (CHD) are one of the most common birth defects. They account for about 6-10% of all infant deaths and 20-40% deaths caused by congenital malformations 5 .
The reported incidence of CHD varies in different studies. It is estimated to occur in about 8-12 infants per 1000 live births (Hoffman, 2002) 6 . Khalil et al in 1994 7 had reported an incidence of 3.9/1000 live births in hospital live births in India. Botto LD et al in 2001 8 reported an incidence of 9/1000 live births. Here in our study, the occurrence of CHD was found to be 8.3/1000 healthy term newborns. This figure has been rising steadily until recently when incidence of 12 to 14/1000 live births, or higher, have been reported in the literature. 9 Some of the reasons for the early lower incidence rates are that only the most severely affected subjects were referred to a cardiac center, that there was relatively little interest and knowledge of CHD by pediatricians and that cardiac surgery had not yet offered the spectacular results that now demand referral of these patients. The increasing use of fetal echocardiography also leads to therapeutic abortion for complex heart diseases, and can substantially reduce the incidence of specific lesions or the total incidence as seen in study by Allan et al 10 . Some studies, such as by Bound et al 11 , deliberately excluded trivial lesions such as mild PS thus giving a low incidence. In contrast, high incidences were found in those studies that examined all or almost all newborn infants in a region, because they detected large numbers of small VSDs and other trivial lesions such as in studies by Hiraishi ei al 12 , Manetti et al 13 and Roguin et al 14 . Therefore, any assessment of the incidence of CHD must take into account the age of the patients and the ways in which they entered the study.
In our study, the most common CHD diagnosed was Ventricular Septal Defect (34. (1996) 15 had observed VSD (36%) as the most common CHD followed by Patent Ductus Arteriosus (9%), Pulmonary stenosis (9%). Indian studies on profile of Congenital heart diseases in India by Shreshtha et al (1980) 16 , Vashihstha et al (1993) 17 , AIIMs study in 1995 and Sharma et al (1996) 18 observed most common CHD to be VSD with respective percentage of 30, 41, 35 and 53 amongst the CHDs diagnosed. However, Kinare et al (1981) 19 observed most common CHD to be Tetrology of Fallot and D-TGA with 9% of all the CHDs diagnosed. Thakur et al (1995) 14 observed ASD to be most common; 38% of all CHDs diagnosed. But the above studies were Licensed Under Creative Commons Attribution CC BY performed in children with age group ranging from 1-16 years. Only the study by AIIMS in 1995 was done in neonates, thus comparable to our study.
In our study, out of 23 diagnosed to have CHD, 12 were male and 11 were female i.e. a male to female ratio of 1.09:1. Study conducted by Daljit S et al 20 had reported a ratio of 1:1, while ratios of 1.1:1 and 1.25:1 are reported from various studies in India. A. Tandon et al 21 had observed higher incidence of CHD in females (53.63%). The male to female ratio of the neonates found to have CHD in our study correlates with the findings stated above. However, a larger sample would be required to have results which could be attributed to the whole population.
Faheem et al 22 (2011) and A Tandon et al 21 (2010) studied the risk factors for CHD in neonates and observed low birth weight to be a significant risk factor for congenital heart disease in association with other risk factors as CHD is a multi factorial disease. Ferencz et al 23 (1997) observed that individuals with lower birth weight (<2,500g) were at a higher risk for the development of CHD than those with birth weight > 2,500g. In our study 15 out of 23 (65.22 %) of neonates diagnosed to have CHDs had birth weight of < 2500 grams. Thus our study also correlates low birth weight with presence CHD but a casual relationship cannot be established between the two.
A Tandon et al 21 and Zheng et al 24 observed that maternal age of < 20 and > 30 both are considered to be a risk factor for the development of CHD. In our study out of 23, 2 mothers had age less than 20 years and 2 were more than 30 years of age. A larger sample size would be required to attribute maternal age as a risk factor for CHDs.
A Tandon et al 21 used case-control status as the dependent variable and maternal therapeutic drug exposure, maternal illness, maternal infection, as co-variates and found significant co-relation with the incidence of CHD. In our study, 2 out of the 23 neonates diagnosed to have CHD had any significant antenatal history. Significant antenatal history found in the two neonates with CHD was as followsone was a mother with Gestational Diabetes Mellitus and the other was an Epileptic mother on Valproate. The other neonates having significant antenatal history in our study did not have any co-relation with CHD.
Myung K. Park 25 observed an increased risk of recurrence of 3% in a neonate with a sibling having a congenital heart disease but only one of the patients diagnosed with CHD in our study had positive family history (parents or sibling). Positive family history of CHD was observed in 11 neonates but they did not screen positive by physical examination or pulse oximetry for CHD. 27 had screened all well babies in the nursery at a median age of 38 hrs of life, Meberg (2008) 3 screened healthy newborns soon after delivery, Riede (2010) 28 had screened full term healthy neonates at 24-72 hrs, Rosatti (2005) 4 had screened term asymptomatic newborns at 72 hrs of life, Sendelbach (2008) 29 had screened > 35 weeks gestation neonates at 4 hrs of life, Tautz (2010) 30 had screened >35 gestation weeks newborns at 6-36 hours, Singh (2014) 31 screened all babies in the postnatal wards <24 hours of life, Turska-Kmiec (2012) 32 screened all babies at the neonatal unit between 2-24 hours of life, Bhola (2014) 33 had screened neonates of >36 weeks of gestational age at 6-72 hours of life and Zhao (2014) 34 screened all babies at 6-72 hours of life. In our study we have screened the newborns three times at preductal and post-ductal sites at <24 hours of life, 48-72 hours and finally 96-120 hours of life.
Thus the results of screening with pulse oximetry in our study are comparable with studies done worldwide with comparable sensitivity and specificity. The diagnostic accuracy of Pulse oximetry as a screening tool is 98.99% thus confirming its utility in routine screening of neonates for CHD.
Conclusions
Congenital heart diseases can be detected early in asymptomatic healthy term newborns with the help of screening by physical examination and pulse oximetry assessment.
The occurrence of Congenital Heart Disease in the given population was observed to be 8.3/1000 asymptomatic healthy term births.
The Sensitivity and Specificity of Pulse Oximetry as a screening tool for Cyanotic Congenital Heart Disease is 88.89% and 99.02% respectively. Thus pulse oximetry can be used an accurate, reliable, cost-effective and easy to use screening tool for detection Cyanotic CHDs. 
